|
Fusion gene ID: 17465 |
FusionGeneSummary for INADL_MAP2K5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: INADL_MAP2K5 | Fusion gene ID: 17465 | Hgene | Tgene | Gene symbol | INADL | MAP2K5 | Gene ID | 10207 | 5607 |
Gene name | PATJ, crumbs cell polarity complex component | mitogen-activated protein kinase kinase 5 | |
Synonyms | Cipp|INADL|InaD-like|hINADL | HsT17454|MAPKK5|MEK5|PRKMK5 | |
Cytomap | 1p31.3 | 15q23 | |
Type of gene | protein-coding | protein-coding | |
Description | inaD-like proteinPALS1-associated tight junction proteinPDZ domain proteinchannel-interacting PDZ domain proteininactivation no after-potential D-like proteininactivation-no-afterpotential D-likeprotein associated to tight junctions | dual specificity mitogen-activated protein kinase kinase 5MAP kinase kinase 5MAP kinase kinase MEK5bMAPK/ERK kinase 5MAPKK 5MEK 5 | |
Modification date | 20180522 | 20180523 | |
UniProtAcc | Q13163 | ||
Ensembl transtripts involved in fusion gene | ENST00000316485, ENST00000371158, ENST00000543708, ENST00000545929, ENST00000472512, | ENST00000178640, ENST00000560591, ENST00000395476, ENST00000354498, ENST00000340972, | |
Fusion gene scores | * DoF score | 8 X 6 X 7=336 | 8 X 7 X 9=504 |
# samples | 9 | 13 | |
** MAII score | log2(9/336*10)=-1.90046432644909 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(13/504*10)=-1.95491211047146 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: INADL [Title/Abstract] AND MAP2K5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | READ | TCGA-DC-6683-01A | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000316485 | ENST00000178640 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000316485 | ENST00000560591 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000316485 | ENST00000395476 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000316485 | ENST00000354498 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000316485 | ENST00000340972 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
In-frame | ENST00000371158 | ENST00000178640 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000371158 | ENST00000560591 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000371158 | ENST00000395476 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000371158 | ENST00000354498 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
5CDS-intron | ENST00000371158 | ENST00000340972 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-3CDS | ENST00000543708 | ENST00000178640 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000543708 | ENST00000560591 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000543708 | ENST00000395476 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000543708 | ENST00000354498 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000543708 | ENST00000340972 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-3CDS | ENST00000545929 | ENST00000178640 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000545929 | ENST00000560591 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000545929 | ENST00000395476 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000545929 | ENST00000354498 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000545929 | ENST00000340972 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-3CDS | ENST00000472512 | ENST00000178640 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000472512 | ENST00000560591 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000472512 | ENST00000395476 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000472512 | ENST00000354498 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
intron-intron | ENST00000472512 | ENST00000340972 | INADL | chr1 | 62274202 | + | MAP2K5 | chr15 | 68040569 | + |
Top |
FusionProtFeatures for INADL_MAP2K5 |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
INADL | MAP2K5 |
Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. | Acts as a scaffold for the formation of a ternaryMAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of thispathway appears to play a critical role in protecting cells fromstress-induced apoptosis, neuronal survival and cardiacdevelopment and angiogenesis. {ECO:0000269|PubMed:7759517,ECO:0000269|PubMed:9384584}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 134_221 | 561 | 1583 | Domain | PDZ 1 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1_65 | 561 | 1583 | Domain | L27 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 248_328 | 561 | 1583 | Domain | PDZ 2 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 365_453 | 561 | 1583 | Domain | PDZ 3 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 134_221 | 561 | 1802 | Domain | PDZ 1 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1_65 | 561 | 1802 | Domain | L27 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 248_328 | 561 | 1802 | Domain | PDZ 2 |
Hgene | INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 365_453 | 561 | 1802 | Domain | PDZ 3 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1068_1160 | 561 | 1583 | Domain | PDZ 6 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1239_1322 | 561 | 1583 | Domain | PDZ 7 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1437_1520 | 561 | 1583 | Domain | PDZ 8 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1533_1615 | 561 | 1583 | Domain | PDZ 9 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 1676_1762 | 561 | 1583 | Domain | PDZ 10 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 553_639 | 561 | 1583 | Domain | PDZ 4 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000316485 | + | 14 | 36 | 686_772 | 561 | 1583 | Domain | PDZ 5 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1068_1160 | 561 | 1802 | Domain | PDZ 6 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1239_1322 | 561 | 1802 | Domain | PDZ 7 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1437_1520 | 561 | 1802 | Domain | PDZ 8 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1533_1615 | 561 | 1802 | Domain | PDZ 9 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 1676_1762 | 561 | 1802 | Domain | PDZ 10 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 553_639 | 561 | 1802 | Domain | PDZ 4 |
Hgene | >INADL | chr1:62274202 | chr15:68040569 | ENST00000371158 | + | 14 | 43 | 686_772 | 561 | 1802 | Domain | PDZ 5 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 166_409 | 358 | 449 | Domain | Protein kinase |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 18_109 | 358 | 449 | Domain | PB1 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 166_409 | 322 | 413 | Domain | Protein kinase |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 18_109 | 322 | 413 | Domain | PB1 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 166_409 | 348 | 439 | Domain | Protein kinase |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 18_109 | 348 | 439 | Domain | PB1 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 172_180 | 358 | 449 | Nucleotide binding | ATP |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 172_180 | 322 | 413 | Nucleotide binding | ATP |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 172_180 | 348 | 439 | Nucleotide binding | ATP |
Top |
FusionGeneSequence for INADL_MAP2K5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_INADL_ENST00000316485_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_652aa MPENPATDKLQVLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKSPLFNQILTLQQSIKQLKGQLNHIPSDCSANFDFSRKGLLVFTDGSI TNGNVHRPSNNSTVSGLFPWTPKLGNEDFNSVIQQMAQGRQIEYIDIERPSTGGLGFSVVALRSQNLGKVDIFVKDVQPGSVADRDQRLK ENDQILAINHTPLDQNISHQQAIALLQQTTGSLRLIVAREPVHTKSSTSSSLNDTTLPETVCWGHVEEVELINDGSGLGFGIVGGKTSGV VVRTIVPGGLADRDGRLQTGDHILKIGGTNVQGMTSEQVAQVLRNCGNSVRMLVARDPAGDISVTPPAPAALPVALPTVASKGPGSDSSL FETYNVELVRKDGQSLGIRIVGYVGTSHTGEASGIYVKSIIPGSAAYHNGHIQVNDKIVAVDGVNIQGFANHDVVEVLRNAGQVVHLTLV RRKTSSSTSPLEPPSDRGTVVEPLKPPALFLTGAVETETNVDGEDEEIKERIDTLKNDNIQALEKLEKVPDSPENELKSRWENLLGPDYE VMVATLDTQIADDAELQKYSKIQKNQGSLMPLQLLQCIVDEDSPVLPVGEFSEPFVHFITQCMRKQPKERPAPEELMGHPFIVQFNDGNA >In-frame_INADL_ENST00000371158_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_652aa MPENPATDKLQVLQVLDRLKMKLQEKGDTSQNEKLSMFYETLKSPLFNQILTLQQSIKQLKGQLNHIPSDCSANFDFSRKGLLVFTDGSI TNGNVHRPSNNSTVSGLFPWTPKLGNEDFNSVIQQMAQGRQIEYIDIERPSTGGLGFSVVALRSQNLGKVDIFVKDVQPGSVADRDQRLK ENDQILAINHTPLDQNISHQQAIALLQQTTGSLRLIVAREPVHTKSSTSSSLNDTTLPETVCWGHVEEVELINDGSGLGFGIVGGKTSGV VVRTIVPGGLADRDGRLQTGDHILKIGGTNVQGMTSEQVAQVLRNCGNSVRMLVARDPAGDISVTPPAPAALPVALPTVASKGPGSDSSL FETYNVELVRKDGQSLGIRIVGYVGTSHTGEASGIYVKSIIPGSAAYHNGHIQVNDKIVAVDGVNIQGFANHDVVEVLRNAGQVVHLTLV RRKTSSSTSPLEPPSDRGTVVEPLKPPALFLTGAVETETNVDGEDEEIKERIDTLKNDNIQALEKLEKVPDSPENELKSRWENLLGPDYE VMVATLDTQIADDAELQKYSKIQKNQGSLMPLQLLQCIVDEDSPVLPVGEFSEPFVHFITQCMRKQPKERPAPEELMGHPFIVQFNDGNA |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_INADL_ENST00000316485_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_1956nt ATGCCTGAAAATCCTGCTACAGATAAACTGCAGGTGCTGCAGGTACTTGATCGCCTGAAAATGAAATTGCAGGAGAAGGGTGACACGTCG CAGAATGAGAAGTTATCTATGTTTTATGAGACACTAAAGAGTCCTCTCTTCAACCAGATACTCACACTTCAGCAGTCCATCAAGCAACTG AAGGGTCAACTCAACCATATACCCTCAGATTGTTCAGCCAACTTTGATTTTTCTAGGAAAGGTTTGTTAGTGTTCACAGATGGTTCCATC ACTAATGGAAATGTCCACAGGCCCTCTAATAACTCGACTGTATCTGGGTTATTTCCGTGGACCCCGAAGTTGGGAAATGAAGACTTTAAC TCAGTCATTCAACAGATGGCTCAGGGCCGGCAAATTGAATATATAGATATAGAACGGCCTTCAACTGGAGGCCTTGGATTCAGTGTGGTG GCCCTCAGAAGTCAAAATCTCGGAAAAGTTGATATCTTCGTGAAGGATGTCCAGCCAGGGAGTGTAGCAGACAGGGATCAAAGATTAAAG GAAAATGATCAAATATTGGCCATTAATCACACGCCATTGGATCAGAACATTTCCCATCAGCAAGCAATTGCATTATTACAACAAACCACT GGATCTTTGAGACTGATTGTGGCCAGGGAACCAGTCCACACAAAAAGCAGTACTTCTAGCAGCCTAAATGATACAACTCTGCCTGAAACA GTTTGTTGGGGCCATGTTGAAGAGGTTGAGCTCATTAATGATGGCTCTGGACTAGGTTTTGGAATAGTTGGAGGAAAAACAAGTGGCGTG GTTGTGAGGACTATAGTTCCTGGAGGATTAGCAGATCGAGATGGAAGACTCCAGACAGGGGACCACATCTTGAAGATTGGTGGCACAAAC GTGCAGGGAATGACCAGTGAGCAAGTTGCACAAGTTCTAAGGAACTGTGGGAATTCAGTCAGGATGCTCGTTGCTAGAGATCCAGCTGGT GACATTTCAGTCACCCCCCCTGCCCCTGCAGCCTTACCTGTTGCCCTGCCTACTGTAGCCAGCAAGGGCCCTGGTTCTGACAGTTCTCTT TTTGAAACTTATAATGTTGAGCTTGTGAGAAAAGATGGGCAGAGTCTTGGAATTAGAATTGTTGGCTATGTTGGAACATCTCATACAGGG GAAGCTTCAGGGATTTATGTGAAAAGTATAATACCTGGCAGTGCTGCGTACCACAATGGCCACATTCAAGTGAATGACAAAATAGTTGCT GTCGATGGCGTGAACATTCAGGGTTTTGCCAACCATGATGTTGTTGAAGTATTACGAAATGCAGGGCAGGTGGTACACCTAACCCTAGTT CGAAGGAAGACATCCTCATCTACTTCTCCACTTGAACCACCTTCAGACAGAGGAACTGTTGTAGAACCACTGAAACCACCAGCTCTCTTT CTAACTGGAGCAGTGGAAACTGAAACTAATGTGGATGGTGAAGATGAGGAAATTAAAGAAAGAATTGATACTTTAAAAAATGACAACATA CAAGCCTTAGAAAAATTGGAAAAAGTCCCAGACTCTCCAGAAAATGAGCTGAAATCCAGATGGGAAAACCTGTTGGGTCCTGATTATGAA GTAATGGTTGCTACTTTGGACACACAGATTGCAGATGATGCTGAGTTACAGAAATATTCAAAGATTCAGAAAAACCAGGGATCTTTAATG CCTCTCCAGCTTCTGCAGTGCATTGTTGATGAGGATTCGCCCGTCCTTCCAGTTGGAGAGTTCTCGGAGCCATTTGTACATTTCATCACT CAGTGTATGCGAAAACAGCCAAAAGAAAGGCCAGCACCTGAAGAATTGATGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCC >In-frame_INADL_ENST00000371158_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_1956nt ATGCCTGAAAATCCTGCTACAGATAAACTGCAGGTGCTGCAGGTACTTGATCGCCTGAAAATGAAATTGCAGGAGAAGGGTGACACGTCG CAGAATGAGAAGTTATCTATGTTTTATGAGACACTAAAGAGTCCTCTCTTCAACCAGATACTCACACTTCAGCAGTCCATCAAGCAACTG AAGGGTCAACTCAACCATATACCCTCAGATTGTTCAGCCAACTTTGATTTTTCTAGGAAAGGTTTGTTAGTGTTCACAGATGGTTCCATC ACTAATGGAAATGTCCACAGGCCCTCTAATAACTCGACTGTATCTGGGTTATTTCCGTGGACCCCGAAGTTGGGAAATGAAGACTTTAAC TCAGTCATTCAACAGATGGCTCAGGGCCGGCAAATTGAATATATAGATATAGAACGGCCTTCAACTGGAGGCCTTGGATTCAGTGTGGTG GCCCTCAGAAGTCAAAATCTCGGAAAAGTTGATATCTTCGTGAAGGATGTCCAGCCAGGGAGTGTAGCAGACAGGGATCAAAGATTAAAG GAAAATGATCAAATATTGGCCATTAATCACACGCCATTGGATCAGAACATTTCCCATCAGCAAGCAATTGCATTATTACAACAAACCACT GGATCTTTGAGACTGATTGTGGCCAGGGAACCAGTCCACACAAAAAGCAGTACTTCTAGCAGCCTAAATGATACAACTCTGCCTGAAACA GTTTGTTGGGGCCATGTTGAAGAGGTTGAGCTCATTAATGATGGCTCTGGACTAGGTTTTGGAATAGTTGGAGGAAAAACAAGTGGCGTG GTTGTGAGGACTATAGTTCCTGGAGGATTAGCAGATCGAGATGGAAGACTCCAGACAGGGGACCACATCTTGAAGATTGGTGGCACAAAC GTGCAGGGAATGACCAGTGAGCAAGTTGCACAAGTTCTAAGGAACTGTGGGAATTCAGTCAGGATGCTCGTTGCTAGAGATCCAGCTGGT GACATTTCAGTCACCCCCCCTGCCCCTGCAGCCTTACCTGTTGCCCTGCCTACTGTAGCCAGCAAGGGCCCTGGTTCTGACAGTTCTCTT TTTGAAACTTATAATGTTGAGCTTGTGAGAAAAGATGGGCAGAGTCTTGGAATTAGAATTGTTGGCTATGTTGGAACATCTCATACAGGG GAAGCTTCAGGGATTTATGTGAAAAGTATAATACCTGGCAGTGCTGCGTACCACAATGGCCACATTCAAGTGAATGACAAAATAGTTGCT GTCGATGGCGTGAACATTCAGGGTTTTGCCAACCATGATGTTGTTGAAGTATTACGAAATGCAGGGCAGGTGGTACACCTAACCCTAGTT CGAAGGAAGACATCCTCATCTACTTCTCCACTTGAACCACCTTCAGACAGAGGAACTGTTGTAGAACCACTGAAACCACCAGCTCTCTTT CTAACTGGAGCAGTGGAAACTGAAACTAATGTGGATGGTGAAGATGAGGAAATTAAAGAAAGAATTGATACTTTAAAAAATGACAACATA CAAGCCTTAGAAAAATTGGAAAAAGTCCCAGACTCTCCAGAAAATGAGCTGAAATCCAGATGGGAAAACCTGTTGGGTCCTGATTATGAA GTAATGGTTGCTACTTTGGACACACAGATTGCAGATGATGCTGAGTTACAGAAATATTCAAAGATTCAGAAAAACCAGGGATCTTTAATG CCTCTCCAGCTTCTGCAGTGCATTGTTGATGAGGATTCGCCCGTCCTTCCAGTTGGAGAGTTCTCGGAGCCATTTGTACATTTCATCACT CAGTGTATGCGAAAACAGCCAAAAGAAAGGCCAGCACCTGAAGAATTGATGGGCCACCCGTTCATCGTGCAGTTCAATGATGGAAATGCC |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_INADL_ENST00000316485_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_2443nt CTCACTTCCGCCCAGGTGAGGCAGGGCCGACACCGAGCCCGCCCGACCCGGGCTCCCACCTGCTCCTCCAGCGCACCAGGTGTCTTTAAG AGTGATTGAAGAGAATAATTCAAAATGCCTGAAAATCCTGCTACAGATAAACTGCAGGTGCTGCAGGTACTTGATCGCCTGAAAATGAAA TTGCAGGAGAAGGGTGACACGTCGCAGAATGAGAAGTTATCTATGTTTTATGAGACACTAAAGAGTCCTCTCTTCAACCAGATACTCACA CTTCAGCAGTCCATCAAGCAACTGAAGGGTCAACTCAACCATATACCCTCAGATTGTTCAGCCAACTTTGATTTTTCTAGGAAAGGTTTG TTAGTGTTCACAGATGGTTCCATCACTAATGGAAATGTCCACAGGCCCTCTAATAACTCGACTGTATCTGGGTTATTTCCGTGGACCCCG AAGTTGGGAAATGAAGACTTTAACTCAGTCATTCAACAGATGGCTCAGGGCCGGCAAATTGAATATATAGATATAGAACGGCCTTCAACT GGAGGCCTTGGATTCAGTGTGGTGGCCCTCAGAAGTCAAAATCTCGGAAAAGTTGATATCTTCGTGAAGGATGTCCAGCCAGGGAGTGTA GCAGACAGGGATCAAAGATTAAAGGAAAATGATCAAATATTGGCCATTAATCACACGCCATTGGATCAGAACATTTCCCATCAGCAAGCA ATTGCATTATTACAACAAACCACTGGATCTTTGAGACTGATTGTGGCCAGGGAACCAGTCCACACAAAAAGCAGTACTTCTAGCAGCCTA AATGATACAACTCTGCCTGAAACAGTTTGTTGGGGCCATGTTGAAGAGGTTGAGCTCATTAATGATGGCTCTGGACTAGGTTTTGGAATA GTTGGAGGAAAAACAAGTGGCGTGGTTGTGAGGACTATAGTTCCTGGAGGATTAGCAGATCGAGATGGAAGACTCCAGACAGGGGACCAC ATCTTGAAGATTGGTGGCACAAACGTGCAGGGAATGACCAGTGAGCAAGTTGCACAAGTTCTAAGGAACTGTGGGAATTCAGTCAGGATG CTCGTTGCTAGAGATCCAGCTGGTGACATTTCAGTCACCCCCCCTGCCCCTGCAGCCTTACCTGTTGCCCTGCCTACTGTAGCCAGCAAG GGCCCTGGTTCTGACAGTTCTCTTTTTGAAACTTATAATGTTGAGCTTGTGAGAAAAGATGGGCAGAGTCTTGGAATTAGAATTGTTGGC TATGTTGGAACATCTCATACAGGGGAAGCTTCAGGGATTTATGTGAAAAGTATAATACCTGGCAGTGCTGCGTACCACAATGGCCACATT CAAGTGAATGACAAAATAGTTGCTGTCGATGGCGTGAACATTCAGGGTTTTGCCAACCATGATGTTGTTGAAGTATTACGAAATGCAGGG CAGGTGGTACACCTAACCCTAGTTCGAAGGAAGACATCCTCATCTACTTCTCCACTTGAACCACCTTCAGACAGAGGAACTGTTGTAGAA CCACTGAAACCACCAGCTCTCTTTCTAACTGGAGCAGTGGAAACTGAAACTAATGTGGATGGTGAAGATGAGGAAATTAAAGAAAGAATT GATACTTTAAAAAATGACAACATACAAGCCTTAGAAAAATTGGAAAAAGTCCCAGACTCTCCAGAAAATGAGCTGAAATCCAGATGGGAA AACCTGTTGGGTCCTGATTATGAAGTAATGGTTGCTACTTTGGACACACAGATTGCAGATGATGCTGAGTTACAGAAATATTCAAAGATT CAGAAAAACCAGGGATCTTTAATGCCTCTCCAGCTTCTGCAGTGCATTGTTGATGAGGATTCGCCCGTCCTTCCAGTTGGAGAGTTCTCG GAGCCATTTGTACATTTCATCACTCAGTGTATGCGAAAACAGCCAAAAGAAAGGCCAGCACCTGAAGAATTGATGGGCCACCCGTTCATC GTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGGGTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGA GGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGGAGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAG AGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTCTGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCA CCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACTGGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTC CCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGGTCAGGCCCGTCAGCATCACTGATGGGAATAAAAGTATTAATGCTTTGT >In-frame_INADL_ENST00000371158_chr1_62274202_+_MAP2K5_ENST00000178640_chr15_68040569_+_2443nt CTCACTTCCGCCCAGGTGAGGCAGGGCCGACACCGAGCCCGCCCGACCCGGGCTCCCACCTGCTCCTCCAGCGCACCAGGTGTCTTTAAG AGTGATTGAAGAGAATAATTCAAAATGCCTGAAAATCCTGCTACAGATAAACTGCAGGTGCTGCAGGTACTTGATCGCCTGAAAATGAAA TTGCAGGAGAAGGGTGACACGTCGCAGAATGAGAAGTTATCTATGTTTTATGAGACACTAAAGAGTCCTCTCTTCAACCAGATACTCACA CTTCAGCAGTCCATCAAGCAACTGAAGGGTCAACTCAACCATATACCCTCAGATTGTTCAGCCAACTTTGATTTTTCTAGGAAAGGTTTG TTAGTGTTCACAGATGGTTCCATCACTAATGGAAATGTCCACAGGCCCTCTAATAACTCGACTGTATCTGGGTTATTTCCGTGGACCCCG AAGTTGGGAAATGAAGACTTTAACTCAGTCATTCAACAGATGGCTCAGGGCCGGCAAATTGAATATATAGATATAGAACGGCCTTCAACT GGAGGCCTTGGATTCAGTGTGGTGGCCCTCAGAAGTCAAAATCTCGGAAAAGTTGATATCTTCGTGAAGGATGTCCAGCCAGGGAGTGTA GCAGACAGGGATCAAAGATTAAAGGAAAATGATCAAATATTGGCCATTAATCACACGCCATTGGATCAGAACATTTCCCATCAGCAAGCA ATTGCATTATTACAACAAACCACTGGATCTTTGAGACTGATTGTGGCCAGGGAACCAGTCCACACAAAAAGCAGTACTTCTAGCAGCCTA AATGATACAACTCTGCCTGAAACAGTTTGTTGGGGCCATGTTGAAGAGGTTGAGCTCATTAATGATGGCTCTGGACTAGGTTTTGGAATA GTTGGAGGAAAAACAAGTGGCGTGGTTGTGAGGACTATAGTTCCTGGAGGATTAGCAGATCGAGATGGAAGACTCCAGACAGGGGACCAC ATCTTGAAGATTGGTGGCACAAACGTGCAGGGAATGACCAGTGAGCAAGTTGCACAAGTTCTAAGGAACTGTGGGAATTCAGTCAGGATG CTCGTTGCTAGAGATCCAGCTGGTGACATTTCAGTCACCCCCCCTGCCCCTGCAGCCTTACCTGTTGCCCTGCCTACTGTAGCCAGCAAG GGCCCTGGTTCTGACAGTTCTCTTTTTGAAACTTATAATGTTGAGCTTGTGAGAAAAGATGGGCAGAGTCTTGGAATTAGAATTGTTGGC TATGTTGGAACATCTCATACAGGGGAAGCTTCAGGGATTTATGTGAAAAGTATAATACCTGGCAGTGCTGCGTACCACAATGGCCACATT CAAGTGAATGACAAAATAGTTGCTGTCGATGGCGTGAACATTCAGGGTTTTGCCAACCATGATGTTGTTGAAGTATTACGAAATGCAGGG CAGGTGGTACACCTAACCCTAGTTCGAAGGAAGACATCCTCATCTACTTCTCCACTTGAACCACCTTCAGACAGAGGAACTGTTGTAGAA CCACTGAAACCACCAGCTCTCTTTCTAACTGGAGCAGTGGAAACTGAAACTAATGTGGATGGTGAAGATGAGGAAATTAAAGAAAGAATT GATACTTTAAAAAATGACAACATACAAGCCTTAGAAAAATTGGAAAAAGTCCCAGACTCTCCAGAAAATGAGCTGAAATCCAGATGGGAA AACCTGTTGGGTCCTGATTATGAAGTAATGGTTGCTACTTTGGACACACAGATTGCAGATGATGCTGAGTTACAGAAATATTCAAAGATT CAGAAAAACCAGGGATCTTTAATGCCTCTCCAGCTTCTGCAGTGCATTGTTGATGAGGATTCGCCCGTCCTTCCAGTTGGAGAGTTCTCG GAGCCATTTGTACATTTCATCACTCAGTGTATGCGAAAACAGCCAAAAGAAAGGCCAGCACCTGAAGAATTGATGGGCCACCCGTTCATC GTGCAGTTCAATGATGGAAATGCCGCCGTGGTGTCCATGTGGGTGTGCCGGGCGCTGGAGGAGAGGCGGAGCCAGCAGGGGCCCCCGTGA GGCTGCCGCAGGGCACTGAAAGCCCAGGACCAGTAACCAAGGAGAACAACCCACCCGTCGCCCTTCTCCGTATGCTGCCTGCGCCAGAAG AGCTTTGCTGGGCCCTGGCTTCCCTGCCCTCGCCTTCACCTCTGTCAGCAGGTGGCCTTGCCTGGGGAGCCCCATGTGTGGCCCACCCCA CCAGGCCATCCCCATACCTTCTGGTTTGAAGGCGCTGACACTGGCAGAGAGGTAAAGGGTGGGGCATTGAGAATGGAGGCTCCCAGGGTC CCTGCCCACTTCTGTTTTCCTAATGTTTTTCTCTATAAAGGGTCAGGCCCGTCAGCATCACTGATGGGAATAAAAGTATTAATGCTTTGT |
Top |
FusionGenePPI for INADL_MAP2K5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
INADL | TJP3, CLDN1, MPP5, ARHGAP17, AMOT, PARD3, BAI1, AMOTL2, LATS1, LATS2, SAV1, YAP1, TP53RK, RNF166, LIN7C, LIN7A, GBA, GJB2, HSF2, SNCA, SLC33A1, RNASEH2A, RAB32, ANAPC15, CEP170P1, CDH1, HOMER3, PCDHAC2, WWC1 | MAP2K5 | MAP3K3, MAP3K2, PRKCZ, MAPK7, MAP2K5, YWHAZ, CDC42BPB, ENO1, SQSTM1, ASRGL1, STAMBP, PRKCI, PARD6A, HSP90AA1, GCH1, XRCC6, ESRRA, RPL28, NXF1, LNX2, TRAF7, C10orf88, CDC37 |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 64_68 | 358 | 449 | MAP3K2/MAP3K3 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 64_68 | 322 | 413 | MAP3K2/MAP3K3 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 64_68 | 348 | 439 | MAP3K2/MAP3K3 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 117_131 | 358 | 449 | MAPK7 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000178640 | + | 16 | 22 | 18_25 | 358 | 449 | MAPK7 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 117_131 | 322 | 413 | MAPK7 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000354498 | + | 16 | 22 | 18_25 | 322 | 413 | MAPK7 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 117_131 | 348 | 439 | MAPK7 |
Tgene | MAP2K5 | chr1:62274202 | chr15:68040569 | ENST00000395476 | + | 15 | 21 | 18_25 | 348 | 439 | MAPK7 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for INADL_MAP2K5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for INADL_MAP2K5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | MAP2K5 | C0005910 | Body Weight | 1 | CTD_human |
Tgene | MAP2K5 | C0011581 | Depressive disorder | 1 | PSYGENET |
Tgene | MAP2K5 | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |